Last update :
29/10/2024
References   References 3787  
Type : Manufacturer

Research teams :
Authors :
Title : Oritavancin diphosphate (Orbactiv®) - Summary of Product Characteristics
Reference : The Medicines Company 2016

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
injectionOritavancin Antibiotic
Factors which affect stability Solvent Sodium chloride 0,9% Induces Precipitation
Stability in solutions Not specified Glucose 5% 1,2 mg/ml 2-8°C Not specified
24 Hour
Stability in solutions Not specified Glucose 5% 1,2 mg/ml 25°C Not specified
12 Hour
Incompatible + Sodium chloride 0,9%

  Mentions Légales